Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors

BACKGROUND: Tumor classification based on their predicted responses to kinase inhibitors is a major goal for advancing targeted personalized therapies. Here, we used a phosphoproteomic approach to investigate biological heterogeneity across hematological cancer cell lines including acute myeloid leu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Casado, Pedro, Alcolea, Maria P, Iorio, Francesco, Rodríguez-Prados, Juan-Carlos, Vanhaesebroeck, Bart, Saez-Rodriguez, Julio, Joel, Simon, Cutillas, Pedro R
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4054101/
https://ncbi.nlm.nih.gov/pubmed/23628362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gb-2013-14-4-r37
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi